Kathryn advises clients through various stages of the business life cycle in matters ranging from corporate governance and venture capital financings to mergers and acquisitions and liquidity events. She represents public and private clients across a wide variety of industries in complex corporate transactions. Kathryn’s practice also includes advising clients on shareholder activism.
Infleqtion to Go Public Through Merger With Churchill Capital Corp X
September 8, 2025
Cooley advised Infleqtion, a global leader in neutral atom-based quantum technology, on its definitive business combination agreement with Churchill Capital Corp X, with the aim to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.
Cooley advised Feedzai, a global leader in fraud and financial crime prevention, on its acquisition of Demyst, including Demyst’s Zonic data workflow orchestration platform, intellectual property and sophisticated data-integration capabilities.
SKIMS Acquires SKKN by Kim From Kim Kardashian and Coty
March 21, 2025
Cooley advised Kim Kardashian, an American media personality, socialite and businesswoman, on SKIMS’ acquisition of SKKN by Kim, a beauty, skincare, and fragrance brand she founded, including the 20% stake held by Coty.
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
March 9, 2025
Cooley advised the special committee of Checkpoint Therapeutics’ (Nasdaq: CKPT) board of directors in connection with Checkpoint’s definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for up to $416 million in cash and contingent value rights.
Cooley advised Tenable Holdings (Nasdaq: TENB), the exposure management company exposing and closing the cybersecurity gaps that erode business value, on its definitive agreement to acquire Vulcan Cyber, an innovator in exposure management, for $150 million in enterprise value.
